in vitro study with the nasogastric tube, CI [Regulatives / Guidelines]

posted by Nataliia – Ukraine, 2021-02-16 13:08 (465 d 06:42 ago) – Posting: # 22211
Views: 1,141

Dear colleagues, does anyone have the experience in conducting in vitro study with the nasogastric tube?

According to FDA Draft Guidance: «The T/R recovery ratio and the 90% confidence interval of the T/R recovery ratio should be calculated», but bioequivalence CI limits were not specified.

Would you kindly write CI limits for in vitro study with the nasogastric tube?
Is it 80,00-125,00?

Complete thread:

UA Flag
Activity
 Admin contact
22,110 posts in 4,630 threads, 1,567 registered users;
online 5 (0 registered, 5 guests [including 4 identified bots]).
Forum time: Friday 20:50 CEST (Europe/Vienna)

We absolutely must leave room for doubt
or there is no progress and no learning.
There is no learning without having to pose a question.
And a question requires doubt.
People search for certainty.
But there is no certainty.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5